Mumbai-based company Supriya Lifescience Ltd, specializing in active pharmaceutical ingredients (API), has announced a groundbreaking collaboration with United States-based Plasma Nutrition, Inc. This exclusive technology licensing agreement grants Supriya Lifescience the sole rights for manufacturing and marketing Ingredient Optimized Protein (ioProtein) in India. The partnership is aimed at introducing this optimized protein into the Indian market, setting a new standard for protein supplements in the region.

ioProtein, a revolutionary protein powder with a patent pending in the US, is designed for high bioavailability, ensuring that higher amounts of proteins are quickly absorbed by the body. This gives it a significant advantage over other protein supplements, making it a more effective and efficient option for consumers.

“We are thrilled to be the exclusive partner of Plasma Nutrition, Inc in introducing the innovative ioProtein to the Indian market,” said Dr Saloni Wagh, Executive Director at Supriya Lifescience Ltd. “This strategic partnership represents our commitment to providing high-nutrition solutions to consumers in India. With ioProtein’s high bioavailability and its unmatched advantage, we are confident that the ‘IO’ technology will revolutionize the nutrition industry and become the preferred choice for health-conscious individuals.”

During the agreement’s term, Supriya Lifescience Ltd will spearhead the manufacturing and marketing of ioProtein in India. This introduction represents a new category of protein powders that are relatively healthier than other popular alternatives available through various gyms, general stores, and digital marketing channels.

“We are excited to collaborate with Supriya Lifescience Ltd and bring our patented ioProtein technology to India,” added Chris Flynn-Rozanski, co-founder & CEO at Plasma Nutrition, Inc. “India’s rapidly growing demand for protein supplements presents an excellent opportunity for us to introduce this highly bioavailable protein powder, which has already been well-received in other markets. We believe this partnership will create a new standard for protein supplementation in India.”

GCV Life Pvt Ltd, led by Shailesh Gadre, was instrumental in facilitating this landmark transaction. Known for its expertise in investment banking and innovation licensing, GCV Life Pvt Ltd will also lead the marketing of the ‘Ingredient Optimized’ products as per the arrangement among the three companies.

This collaboration signifies a transformative step in India’s nutritional supplement industry, aligning with the growing demand for health-conscious products. By making ioProtein widely available, Supriya Lifescience Ltd and Plasma Nutrition, Inc are set to change the way Indians approach protein supplementation.

  Active pharmaceutical ingredients, Chris Flynn-Rozanski, Dr Saloni Wagh, GCV Life, India, ioProtein, Plasma Nutrition, Supriya Lifescience